Literature DB >> 33585089

Incidence of Cardiac Arrhythmias in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention and Associated Outcomes During the First 24 Hours.

Jehangir A Shah1, Farah Naz1, Rajesh Kumar1, Muhammad Hassan1, Ghazanfer Shah1, Khalil Ahmed1, Jamil Hussain1, Khadijah Abid2, Musa Karim3.   

Abstract

Background Acute myocardial infarction (AMI) is the most life-threatening manifestation of coronary artery diseases. The majority of deaths in AMI are due to arrhythmias. Therefore, the aim of this study was to evaluate the incidence and risk factors and outcomes of cardiac arrhythmias in AMI patients undergoing primary percutaneous coronary intervention (PCI) during the first 24 hours of the index hospitalization. Methodology This prospective observational study was conducted at the adult cardiology department of the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan. Patients undergoing primary PCI were included in this study. All the patients were kept under observation for the first 24 hours of AMI and monitored through telemetry system monitoring and the incidence of cardiac arrhythmias and the outcomes were recorded. Results A total of 110 patients were included; the mean age was 59.6±13.1 years. Most of them were male (70.9%). Arrhythmias were observed in 89.1% of the patients, with 169 episodes. The accelerated idioventricular rhythm was the most common type of arrhythmia (37.3%) followed by sinus tachycardia (36.4%), ventricular tachycardia (22.7%), and complete heart block (20.0%). Lethal arrhythmias were observed in 64.5% (71) of the patients. During the hospital course, 65.5% developed arrhythmias during arrival to balloon time, 30% during the procedure, and 53.6% within 24 hours of the procedure. The in-hospital mortality rate was 15.5% with a significant association with the development of lethal arrhythmias within 24 hours of the procedure (21.1% vs. 5.1%; p=0.026). Conclusions The incidence of arrhythmias within 24 hours of hospitalization is high in patients with ST-elevation myocardial infarction (STEMI) undergoing primary PCI, and it has been observed to be associated with an increased rate of in-hospital mortality.
Copyright © 2021, Shah et al.

Entities:  

Keywords:  acute myocardial infarction; cardiac arrhythmias; mortality; outcomes; primary percutaneous coronary intervention; risk factors

Year:  2021        PMID: 33585089      PMCID: PMC7871363          DOI: 10.7759/cureus.12599

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

Review 1.  Risk factors of cardiovascular disease and its recommendations in Pakistani context.

Authors:  Rubina Barolia; Amber Hussain Sayani
Journal:  J Pak Med Assoc       Date:  2017-11       Impact factor: 0.781

2.  Trends in Length of Hospital Stay and the Impact on Prognosis of Early Discharge After a First Uncomplicated Acute Myocardial Infarction.

Authors:  Hoang V Tran; Darleen Lessard; Mayra S Tisminetzky; Jorge Yarzebski; Edgard A Granillo; Joel M Gore; Robert Goldberg
Journal:  Am J Cardiol       Date:  2017-11-22       Impact factor: 2.778

3.  Clinical Impact of Ventricular Tachycardia and/or Fibrillation During the Acute Phase of Acute Myocardial Infarction on In-Hospital and 5-Year Mortality Rates in the Percutaneous Coronary Intervention Era.

Authors:  Masaharu Masuda; Daisaku Nakatani; Shungo Hikoso; Shinichiro Suna; Masaya Usami; Sen Matsumoto; Tetsuhisa Kitamura; Hitoshi Minamiguchi; Yuji Okuyama; Masaaki Uematsu; Takahisa Yamada; Katsuomi Iwakura; Toshimitsu Hamasaki; Yasuhiko Sakata; Hiroshi Sato; Shinsuke Nanto; Masatsugu Hori; Issei Komuro; Yasushi Sakata
Journal:  Circ J       Date:  2016-05-24       Impact factor: 2.993

4.  Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study.

Authors:  Poul Erik Bloch Thomsen; Christian Jons; M J Pekka Raatikainen; Rikke Moerch Joergensen; Juha Hartikainen; Vesa Virtanen; J Boland; Olli Anttonen; Uffe Jakob Gang; Nis Hoest; Lucas V A Boersma; Eivin S Platou; Daniel Becker; Marc D Messier; Heikki V Huikuri
Journal:  Circulation       Date:  2010-09-13       Impact factor: 29.690

5.  Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Christian Juhl Terkelsen; Jacob Thorsted Sørensen; Anne Kjer Kaltoft; Søren Steen Nielsen; Leif Thuesen; Hans-Erik Bøtker; Jens Flensted Lassen
Journal:  Am J Cardiol       Date:  2009-12-15       Impact factor: 2.778

Review 6.  Global Burden of Thrombosis: Epidemiologic Aspects.

Authors:  Aaron M Wendelboe; Gary E Raskob
Journal:  Circ Res       Date:  2016-04-29       Impact factor: 17.367

7.  Percutaneous coronary intervention for acute MI does not prevent in-hospital development of cardiogenic shock compared to fibrinolysis.

Authors:  Matias G Lindholm; Søren Boesgaard; Jens Jakob Thune; Henning Kelbaek; Henning Rud Andersen; Lars Kober
Journal:  Eur J Heart Fail       Date:  2008-06-20       Impact factor: 15.534

Review 8.  Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association.

Authors:  Laxmi S Mehta; Theresa M Beckie; Holli A DeVon; Cindy L Grines; Harlan M Krumholz; Michelle N Johnson; Kathryn J Lindley; Viola Vaccarino; Tracy Y Wang; Karol E Watson; Nanette K Wenger
Journal:  Circulation       Date:  2016-01-25       Impact factor: 29.690

Review 9.  Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.

Authors:  Michèle Bally; Nandini Dendukuri; Benjamin Rich; Lyne Nadeau; Arja Helin-Salmivaara; Edeltraut Garbe; James M Brophy
Journal:  BMJ       Date:  2017-05-09

10.  In-hospital major arrhythmias, arrhythmic death and resuscitation after successful primary percutaneous intervention for acute transmural infarction: a retrospective single-centre cohort study.

Authors:  Marco Albanese; Korhan Alpaslan; Taoufik Ouarrak; Peter Merguet; Steffen Schneider; Wolfgang Schöls
Journal:  BMC Cardiovasc Disord       Date:  2018-06-14       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.